Recombinant Human Rhinovirus 16 VP0 (HRV-VP0)
Recombinant Protein: Human Rhinovirus 16 VP0 (Viral Protein 2, aa70 - 330)
Unit: 50µg
Source: E.coli
Mol. Wt: 39 kD
Purification: Purified from E.coli by multi-step chromatography.
Concentration: See product insert.
Formulation: Preservative-free and carrier-free in 0.2M NaCl, 50mM Tris, 0.5 Arginine, pH 8.0. Filtered through 0.22µm filter.
Storage: Store at -20ºC. Avoid repeated freeze-thaw cycles.
Notes: (1) HRV 16 VP0 has a C-terminal 8xHis-tag. (2) Reactive in Western Blot using anti-VP2 mAb R16-7 (inset, right)
Product Resources: Human Rhinovirus 16 VP0 Certificate of Analysis
For research and commercial use in vitro: not for human in vivo or therapeutic use.
References:
- Bochkov YA and Gern JE. Rhinoviruses and Their Receptors: Implications for Allergic Disease. Curr Allergy Asthma Rep. 2016 Apr;16(4):30.
- Coleman L et al. Rhinovirus-induced asthma exacerbations and risk populations. Curr Opin Allergy Clin Immunol. 2016 Apr;16(2):179-85.
- Hadfield AT et al. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure. 1997 Mar 15;5(3):427-41.
